Besides vaccines, will “monlopiravir” solve the battle of “Corona”?

A study confirms its ability to “extinguish” the virus and prevent its reproduction or transmission of infection

A study conducted by researchers at the Institute of Biomedical Sciences in American Georgia indicated that in the face of the emerging corona virus, the world needs treatments that reduce the risk of complications from the epidemic, in addition to vaccines, noting that they have a candidate who can help to achieve this goal.

The American University researchers confirmed that taking antivirals orally can prevent the spread of “Covid-19”.

The authors of the study, the results of which were published in the scientific journal “Nature Microbiology”, said that the anti-viral drug “Monlopiravir” can prevent the transmission of the Corona virus within 24 hours, according to “Sky News Arabia.”

According to the supervisor of the study, Dr. Richard Plimber, the effective drug against the influenza virus is able to stop the release or transmission of Covid-19, due to its effectiveness against respiratory viruses.

Blimber added: “Scientists noticed after subjecting animals infected with coronavirus to the drug that it reduced the amount of viral particles, which necessarily means reducing the chances of transmission.”

The drug has – according to the researchers – important advantages, the first of which is that it prevents the emergence of severe symptoms of Covid-19, as it shortens the duration of the contagious period, and suppresses the “virus” quickly.

The drug can reduce the reproduction of the virus inside the body, thus greatly reducing the “viral load” of patients.

And if there is not enough virus in the body, then patients will have less severe symptoms; If any, they will also be less likely to infect others around them.

The scientists reached the results of their study based on an experiment in which they injected a group of rodents with the “SARS-Cove-2” virus, and treated them with an anti-viral drug after symptoms of the disease appeared.

After that, the researchers exposed healthy rodents to those that received the drug, but no infection was recorded among those who recovered, which indicates that the infection is not transmitted.

The new corona virus

Besides vaccines, will the medicine “monlopiravir” solve the battle of “Corona”?
Sabaq electronic newspaper
Previously
2020-12-07

A study conducted by researchers at the Institute of Biomedical Sciences in American Georgia indicated that in the face of the emerging corona virus, the world needs treatments that reduce the risk of complications from the epidemic, in addition to vaccines, noting that they have a candidate who can help to achieve this goal.

The American University researchers confirmed that taking antivirals orally can prevent the spread of “Covid-19”.

The authors of the study, the results of which were published in the scientific journal “Nature Microbiology”, said that the anti-viral drug “Monlopiravir” could prevent the transmission of the Corona virus within 24 hours, according to “Sky News Arabia.”

According to the supervisor of the study, Dr. Richard Plimber, the effective drug against the influenza virus is able to stop the release or transmission of Covid-19, due to its effectiveness against respiratory viruses.

Blimber added: “Scientists noticed after subjecting animals infected with coronavirus to the drug that it reduced the amount of viral particles, which necessarily means reducing the chances of transmission.”

The drug has – according to the researchers – important advantages, the first of which is that it prevents the emergence of severe symptoms of Covid-19, as it shortens the duration of the contagious period, and suppresses the “virus” quickly.

The drug can reduce the reproduction of the virus inside the body, thus greatly reducing the “viral load” of patients.

And if there is not enough virus in the body, then patients will have less severe symptoms; If any, they will also be less likely to infect others around them.

The scientists reached the results of their study based on an experiment in which they injected a group of rodents with the “SARS-Cove-2” virus, and treated them with an anti-viral drug after symptoms of the disease appeared.

After that, the researchers exposed healthy rodents to those that received the drug, but no infection was recorded among those who recovered, which indicates that the infection is not transmitted.

07 December 2020 – 22 Rabi al-Thani 1442

10:05 AM


A study confirms its ability to “extinguish” the virus and prevent its reproduction or transmission of infection

A study conducted by researchers at the Institute of Biomedical Sciences in American Georgia indicated that in the face of the emerging corona virus, the world needs treatments that reduce the risk of complications from the epidemic, in addition to vaccines, noting that they have a candidate who can help to achieve this goal.

The American University researchers confirmed that taking antivirals orally can prevent the spread of “Covid-19”.

The authors of the study, the results of which were published in the scientific journal “Nature Microbiology”, said that the anti-viral drug “Monlopiravir” could prevent the transmission of the Corona virus within 24 hours, according to “Sky News Arabia.”

According to the supervisor of the study, Dr. Richard Plimber, the effective drug against the influenza virus is able to stop the release or transmission of Covid-19, due to its effectiveness against respiratory viruses.

Blimber added: “Scientists noticed after subjecting animals infected with coronavirus to the drug that it reduced the amount of viral particles, which necessarily means reducing the chances of transmission.”

The drug has – according to the researchers – important advantages, the first of which is that it prevents the emergence of severe symptoms of Covid-19, as it shortens the duration of the contagious period, and suppresses the “virus” quickly.

The drug can reduce the reproduction of the virus inside the body, thus greatly reducing the “viral load” of patients.

And if there is not enough virus in the body, then patients will have less severe symptoms; If any, they will also be less likely to infect others around them.

The scientists reached the results of their study based on an experiment in which they injected a group of rodents with the “SARS-Cove-2” virus, and treated them with an anti-viral drug after symptoms of the disease appeared.

After that, the researchers exposed healthy rodents to those that received the drug, but no infection was recorded among those who recovered, which indicates that the infection is not transmitted.

window.fbAsyncInit = function() { FB.init({ appId : 636292179804270, autoLogAppEvents : true, xfbml : true, version : 'v2.10' }); FB.AppEvents.logPageView(); };

(function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

These were the details of the news Besides vaccines, will “monlopiravir” solve the battle of “Corona”? for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Donald Trump vows to crush Nikki Haley as Republican race heads south
NEXT FBI director warns that Chinese hackers are preparing to ‘wreak havoc’ on US critical infrastructure